Lidocaine 4% Topical Anesthetic Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidocaine 4% Topical Anesthetic Cream
Generic name: LIDOCAINE 4%
Manufacturer: Oncor Pharmaceuticals
Product type: HUMAN OTC DRUG
SPL set ID: 1baaa669-05af-4024-a0ba-ee3451756f6a
SPL ID: 47a797c4-ddc1-376a-e063-6294a90a469e
Version: 3
Effective date: 2026-01-05
Source export date: 2026-11-06
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/245ea1c0d730b312e4410f082201cbe2cb4d1936fa2918316b6ea631293cbeba/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 08:10:19

Harmonized routes table
Harmonized routes
TOPICAL

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Lidocaine 4% Topical Anesthetic Cream	openfda.brand_name
generic name		LIDOCAINE 4%	openfda.generic_name
manufacturer name		Oncor Pharmaceuticals	openfda.manufacturer_name
ndc	package	83720-523-01	openfda.package_ndc
ndc	product	83720-523	openfda.product_ndc
ndc11	package	83720052301	derived:openfda.package_ndc
rxcui		1421893	openfda.rxcui
spl id		47a797c4-ddc1-376a-e063-6294a90a469e	id
spl set id		1baaa669-05af-4024-a0ba-ee3451756f6a	set_id
unii		98PI200987	openfda.unii

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

Warnings For external use only.

Adverse event summaries are temporarily unavailable. Other product information remains available.